EUVIMEDEUVIMED entdecken
Open Access

Type III interferons induce pyroptosis in gut epithelial cells and impair mucosal repair

Kautilya K Jena, Julien Mambu, Daniel Boehmer, Benedetta Sposito, Virginie Millet, Joshua de Sousa Casal, Hayley I Muendlein, Roberto Spreafico, Romain Fenouil, Lionel Spinelli, Sarah Wurbel, Chloé Riquier und 19 weitere

Cell · 2024-12 · 187 (26) · 7533-7550.e23

DOI: 10.1016/j.cell.2024.10.010 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cell, 2024-12. Verfasst von Kautilya K Jena und 30 weiteren Autor:innen. Beteiligte Einrichtung: Division of Immunology, Harvard Medical School and Boston Children's Hospital, Boston, MA 02115, USA. Hauptthemen laut MEDLINE: Pyroptosis, Intestinal Mucosa, Epithelial Cells, Interferons. Die Arbeit wurde bisher 73-mal zitiert (Crossref) und nennt 85 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, NIDDK NIH HHS, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Tissue damage and repair are hallmarks of inflammation. Despite a wealth of information on the mechanisms that govern tissue damage, mechanistic insight into how inflammation affects repair is lacking. Here, we investigated how interferons influence tissue repair after damage to the intestinal mucosa. We found that type III, not type I or type II, interferons delay epithelial cell regeneration by inducing the upregulation of Z-DNA-binding protein 1 (ZBP1). Z-nucleic acids formed following intestinal damage are sensed by ZBP1, leading to caspase-8 activation and the cleavage of gasdermin C (GSDMC). Cleaved GSDMC drives epithelial cell death by pyroptosis and delays repair of the large or small intestine after colitis or irradiation, respectively. The type III interferon/ZBP1/caspase-8/GSDMC axis is also active in patients with inflammatory bowel disease (IBD). Our findings highlight the capacity of type III interferons to delay gut repair, which has implications for IBD patients or individuals exposed to radiation therapies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PyroptosisIntestinal MucosaEpithelial CellsInterferonsInterferon LambdaHumansAnimalsMiceMice, Inbred C57BLInflammatory Bowel DiseasesColitisCaspase 8RNA-Binding ProteinsMaleRegenerationFemale

Stichwörter der Autor:innen

Z-nucleic acidcolitisdamagegasdermininflammationinflammatory bowel diseaseinterferonsintestinal epithelial cellintestinal stem cellirradiationpattern recognition receptorspyroptosisrepair

Substanzen

InterferonsInterferon LambdaCaspase 8RNA-Binding Proteins

Autor:innen und Institutionen

  • Division of Immunology, Harvard Medical School and Boston Children's Hospital, Boston, MA 02115, USA.
  • Aix Marseille Université, CNRS, INSERM, Centre d'Immunologie de Marseille-Luminy (CIML), 13288 Marseille Cedex, France.
  • Division of Immunology, Harvard Medical School and Boston Children's Hospital, Boston, MA 02115, USA; Department of Medicine II, University Hospital, LMU Munich, 81377 Munich, Germany.
  • Division of Gastroenterology, Harvard Medical School and Boston Children's Hospital, Boston, MA 02115, USA; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA; Program in Immunology, Harvard Medical School, Bo…
  • Department of Immunology, Tufts University School of Medicine, Boston, MA 02111, USA.
  • Institute for Quantitative and Computational Biosciences, University of California, Los Angeles, CA, USA.

Förderung

  • NIAID NIH HHS
  • NIDDK NIH HHS
  • National Institutes of Health
  • NIDDK
  • Deutsche Forschungsgemeinschaft
  • Agence Nationale de la Recherche
  • Critical Infrastructure Resilience Institute, University of Illinois
  • Genentech

Zitieren

APA

Jena, K. K., Mambu, J., Boehmer, D., Sposito, B., Millet, V., de Sousa Casal, J., Muendlein, H. I., Spreafico, R., Fenouil, R., Spinelli, L., Wurbel, S., Riquier, C., Galland, F., Naquet, P., Chasson, L., Elkins, M., Mitsialis, V., Ketelut-Carneiro, N., Bugda Gwilt, K., …, & Zanoni, I. (2024). Type III interferons induce pyroptosis in gut epithelial cells and impair mucosal repair. Cell, 187(26), 7533-7550.e23. https://doi.org/10.1016/j.cell.2024.10.010

Vancouver

Jena KK, Mambu J, Boehmer D, Sposito B, Millet V, de Sousa Casal J, et al. Type III interferons induce pyroptosis in gut epithelial cells and impair mucosal repair. Cell. 2024;187(26):7533-7550.e23. doi:10.1016/j.cell.2024.10.010

BibTeX
@article{Jena2024,
  author = {Jena, Kautilya K and Mambu, Julien and Boehmer, Daniel and Sposito, Benedetta and Millet, Virginie and de Sousa Casal, Joshua and Muendlein, Hayley I and Spreafico, Roberto and Fenouil, Romain and Spinelli, Lionel and Wurbel, Sarah and Riquier, Chloé and Galland, Franck and Naquet, Philippe and Chasson, Lionel and Elkins, Megan and Mitsialis, Vanessa and Ketelut-Carneiro, Natália and Bugda Gwilt, Katlynn and Thiagarajah, Jay R and Ruan, Hai-Bin and Lin, Zhaoyu and Lien, Egil and Shao, Feng and Chou, Janet and Poltorak, Alexander and Ordovas-Montanes, Jose and Fitzgerald, Katherine A and Snapper, Scott B and Broggi, Achille and Zanoni, Ivan},
  title = {Type III interferons induce pyroptosis in gut epithelial cells and impair mucosal repair},
  journal = {Cell},
  year = {2024},
  volume = {187},
  number = {26},
  pages = {7533--7550.e23},
  doi = {10.1016/j.cell.2024.10.010}
}
Kostenlos starten →